Cancer systems biology

Genialis Presents Data at SITC 2023 on RNA-Based Biomarkers to Predict Immunotherapy Response

Retrieved on: 
Friday, November 3, 2023
Technology, Genetics, Clinical Trials, Health Technology, Software, Biotechnology, Health, Pharmaceutical, Oncology, Society for Immunotherapy of Cancer, RNA-Seq, Exact sciences, AUC, Biomarker, Therapy, RNA, Colorectal cancer, Data, PCR, MSI, SITC, Cancer systems biology, San Diego Convention Center, Immunotherapy, Disease, NGS, Microsatellite instability, Biology, Annual general meeting, Biomarker discovery, Gene, Algorithm, Society, Patient, Abstract, DNA, Vaccine, Genial

Genialis , the RNA-biomarker company, today announced new data detailing how RNA sequencing data can help elucidate tumor biologies that may be amenable to immunotherapies and targeted agents.

Key Points: 
  • Genialis , the RNA-biomarker company, today announced new data detailing how RNA sequencing data can help elucidate tumor biologies that may be amenable to immunotherapies and targeted agents.
  • The information was presented in two posters at the Society for Immunotherapy of Cancer's (SITC) 38th Annual Meeting .
  • “RNA biomarkers provide more comprehensive and dynamic insights into cellular states and regulatory processes compared with DNA or protein biomarkers.
  • For more information on ResponderID or to make an appointment with Genialis to learn more, please visit www.genialis.com

Koneksa Appoints Dave Hurry as Chief Data Officer and Dr. Larsson Omberg as EVP of Data Science

Retrieved on: 
Tuesday, June 27, 2023
Science, Other Science, Biotechnology, Research, Pharmaceutical, Health, Health Technology, Clinical Trials, Computational biology, UK Data Service, Sage Bionetworks, Drug development, Data science, Clinical trial, Raymond Lister (computer science researcher), Systems biology, Biomarker, Doctor of Philosophy, Security agency, Invention, Digital health, Patent, Cancer systems biology, Machine learning, Engineering, KTH Royal Institute of Technology, Physics, Artificial intelligence, Knowledge, Growth, Merck, Digital, Biostatistics, Cornell University, Computer science, Management, Medical imaging, Takeda, University of Texas at Austin

Koneksa, the evidence-based digital biomarkers company, today announced the appointment of Dave Hurry as Chief Data Officer and Larsson Omberg, Ph.D., as Executive Vice President of Data Science.

Key Points: 
  • Koneksa, the evidence-based digital biomarkers company, today announced the appointment of Dave Hurry as Chief Data Officer and Larsson Omberg, Ph.D., as Executive Vice President of Data Science.
  • They will focus on applying data science to unlock valuable insights and knowledge from clinical trial data.
  • Dr. Robert Ellis, current Head of Data Science and Co-founder, Koneksa, will transition to Head of Biomarker Exploration.
  • Dr. Larsson Omberg's appointment brings a unique blend of data science, computational biology, research management, and clinical perspective to Koneksa.

Triage Cancer to Present at Free Phoenix Cancer Conference

Retrieved on: 
Thursday, September 22, 2022
Multiple myeloma, Breakfast, Program, Patient, Cancer, Iranian American Bar Association, Quality of life, Caregiver, Arizona State University Downtown Phoenix campus, PBC, Cancer systems biology, Awareness, University, Education, American Bar Association, Mobile phone, Residential care, Health insurance, Takeda

PHOENIX, Sept. 22, 2022 /PRNewswire/ -- The Arizona Myeloma Network and Cancer Caregivers Arizona will host a free, one-day conference on October 26, on "Navigating the Cancer System," featuring Triage Cancer CEO and cancer rights attorney, Joanna Morales , Esq.

Key Points: 
  • PHOENIX, Sept. 22, 2022 /PRNewswire/ -- The Arizona Myeloma Network and Cancer Caregivers Arizona will host a free, one-day conference on October 26, on "Navigating the Cancer System," featuring Triage Cancer CEO and cancer rights attorney, Joanna Morales , Esq.
  • "Navigating the Cancer System" is open to all cancer caregivers, individuals diagnosed with cancer, family members, and cancer care professionals.
  • Morales, who co-founded Triage Cancer in 2012, is one of the only cancer rights attorneys in the country.
  • Cancer Caregivers Arizona provides education and resources that build critical cancer caregiving skills, in the cancer caregivers, cancer patients, other families, and the cancer care professionals.

Single-Cell Genomics Applications in Oncology Therapeutic Development: Resolving the Complexity of Cancer Heterogeneity, Upcoming Webinar Hosted by Xtalks

Retrieved on: 
Tuesday, November 24, 2020
Medicine, Clinical medicine, Oncology, Health, Cancer, Anatomical pathology, Carcinogenesis, Neoplasm, Tumour heterogeneity, Cancer systems biology

This feature of cancer heterogeneity manifests in several ways: intra- and inter-tumor, intra-cellular, as well as spatial and temporal differences.

Key Points: 
  • This feature of cancer heterogeneity manifests in several ways: intra- and inter-tumor, intra-cellular, as well as spatial and temporal differences.
  • With the advent of single-cell genomic technologies, we can now interrogate cancer heterogeneity at a more fundamental level to enable more informed and potentially effective therapeutic strategies in clinical development.
  • For more information, or to register for this event, visit Single-Cell Genomics Applications in Oncology Therapeutic Development: Resolving the Complexity of Cancer Heterogeneity.
  • Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community.